What is GoHealth, Inc.'s earnings per share (EPS)?

GoHealth, Inc. (GOCO) reported diluted earnings per share of -$20.17 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

GoHealth, Inc. (GOCO) Financials

GOCO

Trailing 12 months to March 31, 2026

Revenue $152.8M -81.7% YoY

Net Income -$289.9M -15536.3% YoY

EPS (Diluted) -$20.17 FY2025 annual

Free Cash Flow -$107.8M -83.4% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 18, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 18, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the GOCO SEC filings page.

GoHealth, Inc. (GOCO) reported $152.8M in revenue over the twelve months to Mar 31, 2026, down 81.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GOCO FY2025 2026-10-03

A sharp 2025 revenue contraction exposed a fixed-cost burden, turning near break-even operations into heavy losses and weakening the balance sheet.

After nearing operating break-even in FY2024, FY2025's gross margin fell to 73.4% and operating margin to -114.1%, showing that the revenue shock overwhelmed the cost base. Operating cash flow of -$121.9M alongside $87.3M of interest expense means the cash strain reached beyond reported earnings.

The leverage profile reached 16.8x debt-to-equity in FY2025 as equity shrank to $37.9M. With liabilities of $949.5M, the capital structure leaves a thin equity cushion, so operating volatility now has an amplified effect on reported leverage.

FY2023 converted a net loss into $109.1M of operating cash flow and $95.4M of free cash flow, showing that cash conversion then benefited from items beyond reported profit. By FY2025, both measures were negative—operating cash flow of -$121.9M and free cash flow of -$130.2M—so that earlier support did not persist.

Financial Health Signals

Financial health score not available

GoHealth, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

2/8

GoHealth, Inc. passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

GoHealth, Inc. reported a net loss of $257.1M while operations used $121.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

GoHealth, Inc. reported an operating loss of $412.9M against $87.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$11.9M

YoY-94.6%

QoQ-5.7%

5Y CAGR-43.3%

GoHealth, Inc. generated $11.9M in revenue in Q1 2026. This represents a decrease of 94.6% from the same quarter a year earlier. Against the prior quarter it is down 5.7%.

EBITDA

-$34.5M

YoY-458.0%

GoHealth, Inc.'s EBITDA was -$34.5M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 458.0% from the same quarter a year earlier.

Net Income

-$37.2M

YoY-743.3%

QoQ-14.0%

GoHealth, Inc. reported -$37.2M in net income in Q1 2026. This represents a decrease of 743.3% from the same quarter a year earlier. Against the prior quarter it is down 14.0%.

EPS (Diluted)

-$2.36

GoHealth, Inc. earned -$2.36 per diluted share (EPS) in Q1 2026.

Cash & Balance Sheet

Free Cash Flow

$7.0M

YoY+145.2%

QoQ+117.9%

5Y CAGR-23.9%

GoHealth, Inc. generated $7.0M in free cash flow in Q1 2026, representing cash available after capex. This represents an increase of 145.2% from the same quarter a year earlier. Against the prior quarter it is up 117.9%.

Cash & Debt

$39.9M

YoY+80.0%

QoQ+21.2%

5Y CAGR-25.5%

GoHealth, Inc. held $39.9M in cash against $650.8M in long-term debt as of Q1 2026.

Shares Outstanding

Diluted avg 16M

GoHealth, Inc. had a weighted average of 16M diluted shares in Q1 2026; the shares outstanding count is not reported for that period.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin

30.2%

YoY-52.0pp

QoQ-35.4pp

5Y change-46.1pp

GoHealth, Inc.'s gross margin was 30.2% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is down 52.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 35.4 percentage points.

Return on Equity

-1744.3%

YoY-1742.5pp

QoQ-1658.2pp

5Y change-1743.8pp

GoHealth, Inc.'s ROE was -1744.3% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 1742.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1658.2 percentage points.

Operating Margin

Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

Capital Expenditures

YoY-100.0%

GoHealth, Inc. reported no capital expenditure in Q1 2026. This represents a decrease of 100.0% from the same quarter a year earlier.

R&D Spending

Not reported for Q1 2026.

Share Buybacks

Not reported for Q1 2026.

GOCO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GOCO quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY18
Revenue	$152.8M	$361.8M-54.7%	$798.9M+8.7%	$734.7M+16.3%	$631.7M-40.5%	$1.1B+21.1%	$877.4M	$226.2M
Cost of Revenue	$65.2M	$96.1M-26.4%	$130.6M-17.8%	$159.0M-15.3%	$187.7M-21.6%	$239.3M+20.1%	$199.2M	$79.6M
Gross Profit	$87.6M	$265.7M-60.2%	$668.3M+16.1%	$575.7M+29.7%	$444.0M-46.1%	$823.1M+21.4%	$678.1M	$146.6M
SG&A Expenses	$89.8M	$90.8M+10.6%	$82.1M-11.8%	$93.1M-20.1%	$116.5M+18.7%	$98.2M-50.2%	$197.2M	$27.5M
Operating Income	-$454.4M	-$412.9M-5759.2%	-$7.0M+91.4%	-$81.7M+74.4%	-$318.7M+34.9%	-$489.4M-658.3%	-$64.5M	$28.8M
EBITDA	N/A	-$403.3M-8527.4%	$4.8M+106.8%	-$70.0M+77.1%	-$305.7M+35.8%	-$476.0M-692.7%	-$60.0M	$34.9M
Interest Expense	$102.2M	$87.3M+19.8%	$72.9M+4.9%	$69.5M+21.7%	$57.1M+70.3%	$33.5M+1.6%	$33.0M	$224K
Income Tax	-$3.7M	-$3.3M-247.1%	$2.3M+1372.1%	$154K-79.8%	$764K+3283.3%	-$24K-155.8%	$43K	$46K
Net Income	-$289.9M	-$257.1M-8675.8%	-$2.9M+95.4%	-$63.3M+57.5%	-$148.7M+21.5%	-$189.4M-327.8%	-$44.3M	$28.1M
EPS (Basic)	N/A	-$20.17-2956.1%	-$0.66+90.8%	-$7.19+59.4%	-$17.72+33.9%	-$26.80-700.0%	-$3.35	N/A
EPS (Diluted)	—	-$20.17	-$0.66	-$7.19+59.4%	-$17.72+33.9%	-$26.80	-$3.35	N/A
Diluted Shares (Avg)	N/A	13M	10M	9M+10.0%	8M+19.5%	7M	6M	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$11.9M-94.6%	$12.6M-96.8%	$34.2M-71.1%	$94.0M-11.2%	$221.0M+19.1%	$389.1M+40.6%	$118.3M-10.4%	$105.9M-25.9%
Cost of Revenue	$8.3M-78.8%	$4.3M-91.7%	$20.1M+2.1%	$32.4M+56.7%	$39.3M+3.3%	$52.2M+27.1%	$19.7M-45.3%	$20.7M-43.2%
Gross Profit	$3.6M-98.0%	$8.3M-97.5%	$14.1M-85.7%	$61.6M-27.6%	$181.7M+23.1%	$336.9M+43.0%	$98.6M+2.7%	$85.2M-19.9%
SG&A Expenses	$21.7M-4.3%	$18.5M-41.5%	$27.7M+61.5%	$21.9M+33.8%	$22.7M+33.9%	$31.7M+61.3%	$17.1M+32.2%	$16.4M-56.7%
Operating Income	-$34.8M-621.7%	-$32.3M-140.2%	-$287.9M-574.7%	-$99.4M-144.7%	$6.7M+265.4%	$80.3M+433.0%	-$42.7M-12.4%	-$40.6M+23.4%
EBITDA	-$34.5M-458.0%	N/A	N/A	N/A	$9.6M+840.9%	N/A	N/A	N/A
Interest Expense	$30.8M+93.0%	$29.7M+67.2%	$24.8M+29.7%	$16.9M-6.4%	$16.0M-11.1%	$17.7M-0.1%	$19.1M+8.7%	$18.1M+4.8%
Income Tax	$712K-35.4%	-$3.6M-250.6%	-$486K-4318.2%	-$353K-782.5%	$1.1M+1652.1%	$2.4M+530.3%	-$11K+89.8%	-$40K+45.2%
Net Income	-$37.2M-743.3%	-$32.6M-227.8%	-$165.8M-2547.9%	-$54.3M-108.8%	-$4.4M+52.2%	$25.5M+2175.4%	$6.8M+128.3%	-$26.0M+10.2%
EPS (Basic)	-$2.36-353.8%	N/A	-$11.80-2134.5%	-$5.10-88.9%	-$0.52+50.0%	N/A	$0.58+122.2%	-$2.70+17.4%
EPS (Diluted)	-$2.36	N/A	-$11.80-2665.2%	-$5.10-88.9%	-$0.52+50.0%	N/A	$0.46	-$2.70+17.4%
Diluted Shares (Avg)	16M	N/A	14M-3.0%	11M+8.6%	10M+6.8%	N/A	15M	10M+9.3%

Not reported in any period shown, so not listed: R&D Expenses.

GOCO Balance Sheet

GOCO quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY18
Total Assets	$987.4M-33.7%	$1.5B-0.7%	$1.5B-9.6%	$1.7B-19.8%	$2.1B-1.9%	$2.1B	N/A
Current Assets	$285.8M-28.6%	$400.4M-16.0%	$476.4M+14.9%	$414.6M-3.4%	$429.0M+9.5%	$391.8M	N/A
Cash & Equivalents	$32.9M-19.6%	$40.9M-54.9%	$90.8M+451.6%	$16.5M-80.5%	$84.4M-41.5%	$144.2M	$505K
Short-Term Investments	$0	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$72K-98.4%	$4.5M+1680.8%	$250K-94.7%	$4.7M-72.8%	$17.3M+21.6%	$14.2M	N/A
Long-Term Investments	$0	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	$0-100.0%	$386.6M	N/A
Total Liabilities	$949.5M-23.8%	$1.2B-1.7%	$1.3B-8.8%	$1.4B-19.0%	$1.7B-0.7%	$1.7B	N/A
Current Liabilities	$141.5M-58.1%	$338.1M-8.6%	$370.0M+39.4%	$265.5M+22.3%	$217.1M+70.4%	$127.4M	N/A
Non-Current Liabilities	$851.2M+23.0%	$692.0M+2.6%	$674.6M-15.9%	$802.1M-16.4%	$959.3M+64.8%	$582.3M	N/A
Long-Term Debt	$636.7M+42.2%	$447.9M+6.0%	$422.7M-16.3%	$504.8M-24.1%	$665.1M+67.8%	$396.4M	N/A
Total Equity	$37.9M-84.3%	$241.8M+4.7%	$231.0M-14.0%	$268.8M-23.9%	$353.1M-7.2%	$380.4M	-$186.7M
Retained Earnings	-$680.3M-60.8%	-$423.2M-0.7%	-$420.3M-17.7%	-$357.0M-71.4%	-$208.3M-1008.0%	-$18.8M	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$917.9M-33.6%	$987.4M-33.7%	$1.0B-23.2%	$1.3B+4.3%	$1.4B-0.9%	$1.5B-0.7%	$1.3B-6.7%	$1.3B-15.2%
Current Assets	$264.9M+1.5%	$285.8M-28.6%	$287.5M-13.9%	$288.8M-4.1%	$260.9M-34.3%	$400.4M-16.0%	$334.0M-3.5%	$301.2M-18.2%
Cash & Equivalents	$39.9M+80.0%	$32.9M-19.6%	$32.1M-9.7%	$35.6M+152.0%	$22.2M-77.4%	$40.9M-54.9%	$35.5M+34.6%	$14.1M-44.3%
Accounts Receivable	$1K-100.0%	$72K-98.4%	$2K-100.0%	$143K-98.9%	$5.9M-36.1%	$4.5M+1680.8%	$6.9M-44.7%	$13.5M-62.6%
Total Liabilities	$915.8M-19.7%	$949.5M-23.8%	$962.3M-14.8%	$1.1B+6.2%	$1.1B-2.5%	$1.2B-1.7%	$1.1B-6.6%	$1.1B-14.4%
Current Liabilities	$130.2M-44.2%	$141.5M-58.1%	$175.7M-37.7%	$185.0M-21.0%	$233.4M-22.2%	$338.1M-8.6%	$282.0M+29.5%	$234.0M+11.3%
Non-Current Liabilities	$856.5M+22.8%	$851.2M+23.0%	$805.8M+21.7%	$792.1M+23.0%	$697.7M+5.8%	$692.0M+2.6%	$661.9M-13.6%	$644.1M-15.5%
Long-Term Debt	$650.8M+45.8%	$636.7M+42.2%	$581.8M+39.8%	$560.0M+35.5%	$446.4M+8.8%	$447.9M+6.0%	$416.3M-16.2%	$413.3M-16.7%
Total Equity	$2.1M-99.1%	$37.9M-84.3%	$68.2M-67.9%	$191.8M-5.4%	$241.6M+7.0%	$241.8M+4.7%	$212.0M-7.0%	$202.7M-18.9%
Retained Earnings	-$717.5M-67.8%	-$680.3M-60.8%	-$647.7M-44.4%	-$481.9M-5.8%	-$427.6M+0.4%	-$423.2M-0.7%	-$448.7M-7.1%	-$455.5M-15.3%

Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments, Goodwill.

GOCO Cash Flow Statement

GOCO quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY18
Operating Cash Flow	-$102.6M	-$121.9M-464.4%	-$21.6M-119.8%	$109.1M+79.2%	$60.9M+120.4%	-$299.0M-161.8%	-$114.2M	$5.4M
Depreciation & Amortization	N/A	$9.6M-19.2%	$11.8M+1.2%	$11.7M-9.7%	$12.9M-3.8%	$13.5M+199.2%	$4.5M	$6.2M
Stock-Based Compensation	N/A	$9.2M-18.7%	$11.3M-42.3%	$19.5M-28.0%	$27.1M-0.6%	$27.3M-87.4%	$216.2M	$0
Capital Expenditures	$5.2M	$8.2M-39.9%	$13.7M0.0%	$13.7M+1.6%	$13.5M-31.8%	$19.8M+36.3%	$14.5M	$6.2M
Free Cash Flow	-$107.8M	-$130.2M-268.4%	-$35.3M-137.0%	$95.4M+101.3%	$47.4M+114.9%	-$318.8M-147.6%	-$128.7M	-$727K
Investing Cash Flow	-$5.2M	-$8.2M-316.7%	$3.8M+127.7%	-$13.7M-1.6%	-$13.5M+31.8%	-$19.8M-36.3%	-$14.5M	-$6.2M
Financing Cash Flow	$125.2M	$122.0M+480.8%	-$32.0M-51.8%	-$21.1M+81.7%	-$115.1M-144.4%	$259.1M-0.6%	$260.7M	$63K

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	$7.0M+156.3%	-$39.1M-367.6%	-$32.7M-167.0%	-$37.8M-3.6%	-$12.4M-199.1%	$14.6M-79.5%	-$12.2M-288.1%	-$36.5M-436.0%
Depreciation & Amortization	$307K-89.6%	N/A	N/A	N/A	$3.0M+8.5%	N/A	N/A	N/A
Stock-Based Compensation	$2.6M-8.4%	N/A	$3.5M+22.2%	-$135K-107.1%	$2.8M+57.2%	N/A	$2.9M+624.6%	$1.9M-81.3%
Capital Expenditures	$0-100.0%	$0-100.0%	$2.4M-44.3%	$2.8M+4.7%	$3.0M-33.1%	$2.2M-60.7%	$4.3M+24.1%	$2.7M+11.0%
Free Cash Flow	$7.0M+145.2%	-$39.1M-415.5%	-$35.0M-112.5%	-$40.6M-3.7%	-$15.5M-294.2%	$12.4M-81.1%	-$16.5M-636.3%	-$39.2M-565.1%
Investing Cash Flow	$0+100.0%	$0+100.0%	-$2.4M-117.8%	-$2.8M-4.7%	-$3.0M+33.1%	-$2.2M+60.7%	$13.3M+487.6%	-$2.7M-11.0%
Financing Cash Flow	-$25K+99.2%	$39.9M+672.7%	$31.4M+54.6%	$53.9M+221.2%	-$3.2M-239.3%	-$7.0M-541.1%	$20.3M+1026.9%	-$44.4M-188.1%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

GOCO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GOCO quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY18
Gross Margin	73.4%-10.2pp	83.7%+5.3pp	78.4%+8.1pp	70.3%-7.2pp	77.5%+0.2pp	77.3%	64.8%
Operating Margin	-114.1%	-0.9%+10.2pp	-11.1%+39.3pp	-50.4%-4.4pp	-46.1%-38.7pp	-7.4%	12.7%
Net Margin	-71.1%-70.7pp	-0.4%+8.2pp	-8.6%+14.9pp	-23.5%-5.7pp	-17.8%-12.8pp	-5.1%	12.4%
Return on Equity	-678.9%-677.7pp	-1.2%+26.2pp	-27.4%+28.0pp	-55.3%-1.7pp	-53.6%-42.0pp	-11.6%	N/A
Return on Assets	-26.0%-25.8pp	-0.2%+4.0pp	-4.2%+4.7pp	-9.0%+0.2pp	-9.2%-7.0pp	-2.1%	N/A
Current Ratio	2.02+0.8x	1.18-0.1x	1.29-0.3x	1.56-0.4x	1.98-1.1x	3.08	N/A
Debt-to-Equity	16.81+15.0x	1.850.0x	1.830.0x	1.880.0x	1.88+0.8x	1.04	N/A
Asset Turnover	0.37-0.2x	0.540.0x	0.49+0.1x	0.38-0.1x	0.51+0.1x	0.42	N/A
FCF Margin	-36.0%-31.6pp	-4.4%-17.4pp	13.0%+5.5pp	7.5%+37.5pp	-30.0%-15.3pp	-14.7%	-0.3%

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Gross Margin	30.2%-52.0pp	65.6%-21.0pp	41.2%-42.1pp	65.5%-14.9pp	82.2%+2.7pp	86.6%+1.4pp	83.4%+10.6pp	80.5%+6.0pp
Operating Margin	-292.0%	-255.3%	-842.2%	-105.7%	3.0%+5.2pp	20.6%+15.2pp	-36.1%-7.3pp	-38.4%-1.2pp
Net Margin	-312.0%	-257.9%	-485.1%	-57.7%-33.2pp	-2.0%+3.0pp	6.6%+7.0pp	5.7%+23.8pp	-24.6%-4.3pp
Return on Equity	-1744.3%-1742.5pp	-86.1%-96.6pp	-243.3%-246.5pp	-28.3%-15.5pp	-1.8%+2.3pp	10.5%+11.1pp	3.2%+13.7pp	-12.8%-1.2pp
Return on Assets	-4.0%-3.7pp	-3.3%-5.0pp	-16.1%-16.6pp	-4.1%-2.1pp	-0.3%+0.3pp	1.7%+1.8pp	0.5%+2.2pp	-2.1%-0.1pp
Current Ratio	2.03+0.9x	2.02+0.8x	1.64+0.5x	1.56+0.3x	1.12-0.2x	1.18-0.1x	1.18-0.4x	1.29-0.5x
Debt-to-Equity	305.38+303.5x	16.81+15.0x	8.54+6.6x	2.92+0.9x	1.850.0x	1.850.0x	1.96-0.2x	2.04+0.1x
Asset Turnover	0.01-0.1x	0.01-0.2x	0.03-0.1x	0.070.0x	0.160.0x	0.26+0.1x	0.090.0x	0.080.0x
FCF Margin	58.6%+65.6pp	-309.1%	-102.5%	-43.2%-6.2pp	-7.0%-11.3pp	3.2%-20.6pp	-13.9%-16.3pp	-37.0%-42.9pp

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
GoHealth, Inc. GOCO	FY2025	$361.8M	-$257.1M	-71.1%	$8.9M	—
eHealth, Inc. EHTH	FY2025	$554.0M	$40.0M	7.2%	$22.4M	18/100
AIFU Inc. AIFU	FY2025	$79.6M	-$325.4M	N/A	$71.2M	23/100
XChange TEC.INC XHG	FY2025	$51.3M	-$105.1M	N/A	$117.5M	1/100
TIAN RUIXIANG Holdings Ltd TIRX	FY2024	$5.4M	$617K	11.4%	$2.7M	24/100
SelectQuote, Inc. SLQT	FY2026	$1.6B	$62.2M	3.8%	$64.2M	13/100

Where GoHealth, Inc. Ranks

Frequently Asked Questions

What is GoHealth, Inc.'s annual revenue?

GoHealth, Inc. (GOCO) reported $361.8M in total revenue for fiscal year 2025. This represents a -54.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is GoHealth, Inc.'s revenue growing?

GoHealth, Inc. (GOCO) revenue declined by 54.7% year-over-year, from $798.9M to $361.8M in fiscal year 2025.

Is GoHealth, Inc. profitable?

No, GoHealth, Inc. (GOCO) reported a net income of -$257.1M in fiscal year 2025, with a net profit margin of -71.1%.

What is GoHealth, Inc.'s EBITDA?

GoHealth, Inc. (GOCO) had EBITDA of -$403.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does GoHealth, Inc. have?

As of fiscal year 2025, GoHealth, Inc. (GOCO) had $32.9M in cash and equivalents against $636.7M in long-term debt.

What is GoHealth, Inc.'s gross margin?

GoHealth, Inc. (GOCO) had a gross margin of 73.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is GoHealth, Inc.'s net profit margin?

GoHealth, Inc. (GOCO) had a net profit margin of -71.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is GoHealth, Inc.'s return on equity (ROE)?

GoHealth, Inc. (GOCO) has a return on equity of -678.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is GoHealth, Inc.'s free cash flow?

GoHealth, Inc. (GOCO) recorded an outflow of $130.2M in free cash flow during fiscal year 2025. This represents a -268.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is GoHealth, Inc.'s operating cash flow?

GoHealth, Inc. (GOCO) recorded an outflow of $121.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are GoHealth, Inc.'s total assets?

GoHealth, Inc. (GOCO) had $987.4M in total assets as of fiscal year 2025, including both current and long-term assets.

What are GoHealth, Inc.'s capital expenditures?

GoHealth, Inc. (GOCO) invested $8.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

What is GoHealth, Inc.'s current ratio?

GoHealth, Inc. (GOCO) had a current ratio of 2.02 as of fiscal year 2025, which is generally considered healthy.

What is GoHealth, Inc.'s debt-to-equity ratio?

GoHealth, Inc. (GOCO) had a debt-to-equity ratio of 16.81 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is GoHealth, Inc.'s return on assets (ROA)?

GoHealth, Inc. (GOCO) had a return on assets of -26.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is GoHealth, Inc.'s Piotroski F-Score?

GoHealth, Inc. (GOCO) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are GoHealth, Inc.'s earnings high quality?

GoHealth, Inc. (GOCO) reported a net loss of $257.1M while operations used $121.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can GoHealth, Inc. cover its interest payments?

GoHealth, Inc. (GOCO) reported an operating loss of $412.9M against $87.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.